Meetings and events continue to be an effective way to get doctors'attention, according to Scott-Levin's US Total Promotion Report Generator System Physician Meeting & Event Audit. Doctors are more likely to accept invitations to events associated with a pharmaceutical company; while physicians said yes to only 40% of invitations not associated with a manufacturer last year, they accepted 49% of those associated with a drug firm.
However, who makes the invitation matters. The audit found that pharmaceutical sales representatives extended 65% of all invitations, but physicians accepted only about half (47%) of these. Doctors were more likely to say yes when a third-party organization made the invitation on behalf of the manufacturer. In such situations, physicians accepted 59% of the time.
Wave of creativity in invitations
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze